1
|
Kim S, Lee K. A Network Analysis of Depressive Symptoms in the Elderly with Subjective Memory Complaints. J Pers Med 2022; 12:jpm12050821. [PMID: 35629243 PMCID: PMC9145813 DOI: 10.3390/jpm12050821] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2022] [Revised: 05/16/2022] [Accepted: 05/17/2022] [Indexed: 11/16/2022] Open
Abstract
(1) Background: Subjective memory complaints (SMCs) are common among the elderly and are important because they can indicate early cognitive impairment. The factor with the greatest correlation with SMCs is depression. The purpose of this study is to examine depressive symptoms among elderly individuals with SMCs through a network analysis that can analyze disease models between symptoms; (2) Methods: A total of 3489 data collected from elderly individuals in the community were analyzed. The Subjective Memory Complaints Questionnaire and Patient Health Questionnaire-9 were evaluated. For statistical analysis, we investigated the features of the depressive symptoms network, including centrality and clustering; (3) Results: Network analysis of the SMC group showed strong associations in the order of Q1–Q2 (r = 0.499), Q7–Q8 (r = 0.330), and Q1–Q6 (r = 0.239). In terms of centrality index, Q2 was highest in strength and expected influence, followed by Q1 in all of betweenness, strength, and expected influence; (4) Conclusions: The network analysis confirmed that the most important factors in the subjective cognitive decline group were depressed mood and anhedonia, which also had a strong correlation in the network pattern.
Collapse
|
2
|
Ha GE, Cheong E. Chronic Restraint Stress Decreases the Excitability of Hypothalamic POMC Neuron and Increases Food Intake. Exp Neurobiol 2021; 30:375-386. [PMID: 34983879 PMCID: PMC8752322 DOI: 10.5607/en21037] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2021] [Revised: 12/08/2021] [Accepted: 12/11/2021] [Indexed: 11/19/2022] Open
Abstract
Stress activates the hypothalamic-pituitary-adrenal system, and induces the release of glucocorticoids, stress hormones, into circulation. Many studies have shown that stress affects feeding behavior, however, the underlying circuitry and molecular mechanisms are not fully understood. The balance between orexigenic (simulating appetite) and anorexigenic (loss of appetite) signals reciprocally modulate feeding behavior. It is suggested that proopiomelanocortin (POMC) and neuropeptide Y (NPY) neurons in the arcuate nucleus (ARC) of the hypothalamus are the first-order neurons that respond to the circulating signals of hunger and satiety. Here, we examined a chronic restraint stress model and observed an increase in food intake, which was not correlated with anhedonia. We investigated whether stress affects the properties of POMC and NPY neurons and found that chronic restraint stress reduced the excitatory inputs onto POMC neurons and increased the action potential threshold. Therefore, our study suggests that chronic stress modulates the intrinsic excitability and excitatory inputs in POMC neurons, leading to changes in feeding behavior.
Collapse
Affiliation(s)
- Go Eun Ha
- Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul 03722, Korea
| | - Eunji Cheong
- Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul 03722, Korea
| |
Collapse
|
3
|
Graham E, Watson T, Deschênes SS, Filion KB, Henderson M, Harper S, Rosella LC, Schmitz N. Depression-related weight change and incident diabetes in a community sample. Sci Rep 2021; 11:13575. [PMID: 34193888 PMCID: PMC8245524 DOI: 10.1038/s41598-021-92963-w] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2021] [Accepted: 06/09/2021] [Indexed: 02/05/2023] Open
Abstract
This cohort study aimed to compare the incidence of type 2 diabetes in adults with depression-related weight gain, depression-related weight loss, depression with no weight change, and no depression. The study sample included 59,315 community-dwelling adults in Ontario, Canada. Depression-related weight change in the past 12 months was measured using the Composite International Diagnostic Interview-Short Form. Participants were followed for up to 20 years using administrative health data. Cox proportional hazards models compared the incidence of type 2 diabetes in adults with depression-related weight change and in adults with no depression. Adults with depression-related weight gain had an increased risk of type 2 diabetes compared to adults no depression (HR 1.70, 95% CI 1.32-2.20), adults with depression-related weight loss (HR 1.62, 95% CI 1.09-2.42), and adults with depression with no weight change (HR 1.39, 95% CI 1.03-1.86). Adults with depression with no weight change also had an increased risk of type 2 diabetes compared to those with no depression (HR 1.23, 95% CI 1.04-1.45). Associations were stronger among women and persisted after adjusting for attained overweight and obesity. Identifying symptoms of weight change in depression may aid in identifying adults at higher risk of type 2 diabetes and in developing tailored prevention strategies.
Collapse
Affiliation(s)
- Eva Graham
- Department of Epidemiology, Biostatistics, and Occupational Health, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada.
- Douglas Mental Health University Institute, 6875 LaSalle Boulevard, QC, H4H 1R3, Verdun, Canada.
| | | | | | - Kristian B Filion
- Department of Epidemiology, Biostatistics, and Occupational Health, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada
- Jewish General Hospital, Lady Davis Institute, Montreal, QC, Canada
- Department of Medicine, McGill University, Montreal, QC, Canada
| | - Mélanie Henderson
- Department of Pediatrics, Université de Montréal, Montreal, QC, Canada
- Centre de Recherche CHU Sainte-Justine, Montreal, QC, Canada
- School of Public Health, Department of Social and Preventive Medicine, Université de Montréal, Montreal, QC, Canada
| | - Sam Harper
- Department of Epidemiology, Biostatistics, and Occupational Health, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada
| | - Laura C Rosella
- ICES, Toronto, ON, Canada
- Epidemiology Division, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada
| | - Norbert Schmitz
- Department of Epidemiology, Biostatistics, and Occupational Health, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada
- Douglas Mental Health University Institute, 6875 LaSalle Boulevard, QC, H4H 1R3, Verdun, Canada
- Department of Psychiatry, Faculty of Medicine, McGill University, Montreal, QC, Canada
- Department of Population-Based Medicine, Institute of Health Sciences, University Hospital Tuebingen, Tuebingen, Germany
| |
Collapse
|
4
|
Barahona-Correa JE, Aristizabal-Mayor JD, Lasalvia P, Ruiz ÁJ, Hidalgo-Martínez P. Sleep disturbances, academic performance, depressive symptoms and substance use among medical students in Bogota, Colombia. ACTA ACUST UNITED AC 2018; 11:260-268. [PMID: 30746044 PMCID: PMC6361310 DOI: 10.5935/1984-0063.20180041] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
Objective: Poor sleep patterns are common in undergraduates and may turn them prone to
mood disorders, substance abuse and impaired academic performance. The aim
of this study was to assess sleep disturbances among medical students, and
whether associations with academic performance, depressive symptoms or
substance use were present. Methods: Cross-sectional study in which 544 medical students of the Pontificia
Universidad Javeriana in Bogota, Colombia were included. Using a
computer-based survey, self-reported variables were assessed, including
demographics, Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness
Scale (ESS), Berlin Questionnaire, Diagnostic and Statistical Manual
of Mental Disorders (DSM) - IV depression criteria, Grade Point
Average (GPA), and substance use. Associations between these variables were
obtained. Results: Fifty-four percent of students were women. Poor sleep quality (PSQI>5) and
daytime sleepiness (ESS>10) were found in 65% of the population. A higher
GPA was more frequent in students with good sleep quality (OR= 2.6
[1.5-4.5]), lack of daytime sleepiness (OR= 2 [1.3-3.1]) and low risk of
Obstructive Sleep Apnea Syndrome (OSAS) (OR= 3.1 [1.6-5.9]). DSM-IV
depression criteria were fulfilled by 26% of the students and were
associated with poor sleep patterns. Energy drinks use was associated with
poor sleep quality. Discussion: Poor sleep quality, daytime sleepiness and depressive symptoms are frequent
among medical students and are associated with lower academic performance.
The identification of students at risk and the implementation of targeted
interventions are warranted. Fostering adequate sleep habits and training on
sleep medicine may partly counteract these issues.
Collapse
Affiliation(s)
| | | | | | - Álvaro J Ruiz
- Pontificia Universidad Javeriana, Department of Clinical Epidemiology and Biostatistics - Bogota - Cundinamarca - Colombia.,Pontificia Universidad Javeriana, Department of Internal Medicine, School of Medicine - Bogota - Cundinamarca - Colombia
| | - Patricia Hidalgo-Martínez
- Pontificia Universidad Javeriana, Department of Internal Medicine, School of Medicine - Bogota - Cundinamarca - Colombia.,Hospital Universitario San Ignacio, Sleep Medicine Division - Bogota - Cundinamarca - Colombia
| |
Collapse
|
5
|
Down-regulation of cholinergic signaling in the habenula induces anhedonia-like behavior. Sci Rep 2017; 7:900. [PMID: 28420875 PMCID: PMC5429859 DOI: 10.1038/s41598-017-01088-6] [Citation(s) in RCA: 41] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2016] [Accepted: 03/23/2017] [Indexed: 11/30/2022] Open
Abstract
Dysfunction of cholinergic signaling in the brain has long been believed to be associated with depressive disorders. However, the functional impact of habenular cholinergic signaling on the specified depressive behaviors is not well understood. Here, we demonstrated that the expression levels of cholinergic signaling genes (CHAT, VACHT, CHT, CHRNA3, CHRNB3 and CHRNB4) were down-regulated in a chronic restraint stress (CRS) rat model of depression, in which rats display depression-like behaviors such as anhedonia and mood despair. Moreover, knockdown of CHAT in the rat habenula was sufficient to evoke anhedonia-like behavior. The anhedonia-like behavior induced by CHAT knockdown was not reversed by chronic administration of the selective serotonin reuptake inhibitor fluoxetine. To determine whether habenular cholinergic signaling is associated with regulation of dopamine neurons in the ventral tegmental area (VTA) and serotonin neurons in the dorsal raphe nucleus (DRN), we used CHAT::cre transgenic mice expressing the Designer Receptors Exclusively Activated by Designer Drugs (DREADD). Pharmacogenetic activation of habenular cholinergic neurons induces the excitation of dopamine neurons in the VTA and reduces the immunoreactivity of 5-hydroxytryptamine (5-HT) in the DRN. Habenular cholinergic gene down-regulation was recapitulated in the postmortem habenula of suicide victims diagnosed with major depressive disorder (MDD).
Collapse
|
6
|
Parvaz MA, Gabbay V, Malaker P, Goldstein RZ. Objective and specific tracking of anhedonia via event-related potentials in individuals with cocaine use disorders. Drug Alcohol Depend 2016; 164:158-165. [PMID: 27226335 PMCID: PMC4893885 DOI: 10.1016/j.drugalcdep.2016.05.004] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/17/2016] [Revised: 04/25/2016] [Accepted: 05/06/2016] [Indexed: 11/30/2022]
Abstract
BACKGROUND Hyposensitivity to non-drug reward, behaviorally manifested as anhedonia, is a hallmark of chronic substance use. Anhedonia is a transdiagnostic symptom underpinned by neurobiochemical disturbances in the reward circuit, yet an objective measure to assess anhedonia severity still eludes the field. We hypothesized that the Reward Positivity (RewP) component of the event-related potentials (ERPs) will specifically track anhedonia as the RewP is attributed to the same brain regions that are also implicated in anhedonia. METHODS Forty-six individuals with cocaine use disorders (iCUD) performed a gambling task predicting whether they would win or lose money on each trial, while ERP data was acquired. RewP in response to predicted win trials was extracted from the ERPs using the principal component analysis. State anhedonia and depression severity were assessed using the Cocaine Selective Severity Assessment (CSSA). RESULTS Although RewP amplitude correlated with both anhedonia and depression, only the RewP-anhedonia correlation survived a correction for depression severity. Further, a hierarchical multiple regression analysis revealed that anhedonia explained a significant amount of variance in the RewP amplitude, and this variance was significantly greater than that explained by demographics, severity and recency of drug use and even depression. CONCLUSIONS These results show that RewP amplitude in response to rewarded trials tracks state anhedonia severity in iCUD. We argue that this association is perhaps driven by the activity in the dopaminergic mesocorticolimbic reward pathway that may underlie anhedonia symptomology as well as modulate RewP amplitude.
Collapse
Affiliation(s)
- Muhammad A. Parvaz
- Icahn School of Medicine at Mount Sinai, New York, NY 10029 USA,Correspondence may be addressed to: Muhammad A Parvaz, One Gustave L. Levy Place, Box 1230, New York, NY 10029-6574; Tel: 212-241-3638; Fax: 212-803-6743;
| | - Vilma Gabbay
- Icahn School of Medicine at Mount Sinai, New York, NY 10029 USA,Nathan Kline Institute for Psychiatric Research Orangeburg, NY 10962 USA
| | - Pias Malaker
- Icahn School of Medicine at Mount Sinai, New York, NY 10029 USA
| | - Rita Z. Goldstein
- Icahn School of Medicine at Mount Sinai, New York, NY 10029 USA,Correspondence may also be addressed to Rita Z. Goldstein, 1470 Madison Ave., New York, NY 10029-6574; Tel: 212-824-9312;
| |
Collapse
|
7
|
Leventhal AM, Zvolensky MJ. Anxiety, depression, and cigarette smoking: a transdiagnostic vulnerability framework to understanding emotion-smoking comorbidity. Psychol Bull 2015; 141:176-212. [PMID: 25365764 PMCID: PMC4293352 DOI: 10.1037/bul0000003] [Citation(s) in RCA: 333] [Impact Index Per Article: 37.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Research into the comorbidity between emotional psychopathology and cigarette smoking has often focused upon anxiety and depression's manifest symptoms and syndromes, with limited theoretical and clinical advancement. This article presents a novel framework to understanding emotion-smoking comorbidity. We propose that transdiagnostic emotional vulnerabilities-core biobehavioral traits reflecting maladaptive responses to emotional states that underpin multiple types of emotional psychopathology-link various anxiety and depressive psychopathologies to smoking. This framework is applied in a review and synthesis of the empirical literature on 3 transdiagnostic emotional vulnerabilities implicated in smoking: (a) anhedonia (Anh; diminished pleasure/interest in response to rewards), (b) anxiety sensitivity (AS; fear of anxiety-related sensations), and (c) distress tolerance (DT; ability to withstand distressing states). We conclude that Anh, AS, and DT collectively (a) underpin multiple emotional psychopathologies, (b) amplify smoking's anticipated and actual affect-enhancing properties and other mechanisms underlying smoking, (c) promote progression across the smoking trajectory (i.e., initiation, escalation/progression, maintenance, cessation/relapse), and (d) are promising targets for smoking intervention. After existing gaps are identified, an integrative model of transdiagnostic processes linking emotional psychopathology to smoking is proposed. The model's key premise is that Anh amplifies smoking's anticipated and actual pleasure-enhancing effects, AS amplifies smoking's anxiolytic effects, and poor DT amplifies smoking's distress terminating effects. Collectively, these processes augment the reinforcing properties of smoking for individuals with emotional psychopathology to heighten risk of smoking initiation, progression, maintenance, cessation avoidance, and relapse. We conclude by drawing clinical and scientific implications from this framework that may generalize to other comorbidities.
Collapse
Affiliation(s)
- Adam M Leventhal
- Department of Psychology, Keck School of Medicine, University of Southern California
| | | |
Collapse
|
8
|
Zimmerman M, Ellison W, Young D, Chelminski I, Dalrymple K. How many different ways do patients meet the diagnostic criteria for major depressive disorder? Compr Psychiatry 2015; 56:29-34. [PMID: 25266848 DOI: 10.1016/j.comppsych.2014.09.007] [Citation(s) in RCA: 161] [Impact Index Per Article: 17.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/25/2014] [Revised: 08/28/2014] [Accepted: 09/03/2014] [Indexed: 12/19/2022] Open
Abstract
There are 227 possible ways to meet the symptom criteria for major depressive disorder (MDD). However, symptom occurrence is not random, and some symptoms co-occur significantly beyond chance. This raises the questions of whether all of the theoretically possible different ways of meeting the MDD criteria actually occur in patients, and whether some combinations of criteria are much more common than others. More than 1500 patients who met DSM-IV criteria for MDD at the time of the evaluation were interviewed with semi-structured interviews. The patients met the MDD symptom criteria in 170 different ways. Put another way, one-quarter (57/227) of the criteria combinations did not occur. The most frequent combination was the presence of all 9 criteria (10.1%, n=157). Nine combinations (all 9 criteria, 3 of the 8-criterion combinations, 4 of the 7-criterion combinations, and one 6-criterion combination) were present in more than 2% of the patients, together accounting for more than 40% of the diagnoses. The polythetic definition of MDD, which requires a minimum number of criteria from a list, results in significant diagnostic heterogeneity because there are many different ways to meet criteria. While there is significant heterogeneity amongst patients meeting the MDD diagnostic criteria, a relatively small number of combinations could be considered as diagnostic prototypes as they account for more than 40% of the patients diagnosed with MDD.
Collapse
Affiliation(s)
- Mark Zimmerman
- Department of Psychiatry and Human Behavior, Brown Medical School; Department of Psychiatry, Rhode Island Hospital, Providence.
| | - William Ellison
- Department of Psychiatry and Human Behavior, Brown Medical School; Department of Psychiatry, Rhode Island Hospital, Providence
| | - Diane Young
- Department of Psychiatry and Human Behavior, Brown Medical School; Department of Psychiatry, Rhode Island Hospital, Providence
| | - Iwona Chelminski
- Department of Psychiatry and Human Behavior, Brown Medical School; Department of Psychiatry, Rhode Island Hospital, Providence
| | - Kristy Dalrymple
- Department of Psychiatry and Human Behavior, Brown Medical School; Department of Psychiatry, Rhode Island Hospital, Providence
| |
Collapse
|
9
|
Trujols J, Feliu-Soler A, de Diego-Adeliño J, Portella MJ, Cebrià Q, Soler J, Puigdemont D, Alvarez E, Perez V. A psychometric analysis of the Clinically Useful Depression Outcome Scale (CUDOS) in Spanish patients. J Affect Disord 2013; 151:920-3. [PMID: 24035487 DOI: 10.1016/j.jad.2013.08.007] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/25/2013] [Revised: 08/08/2013] [Accepted: 08/08/2013] [Indexed: 10/26/2022]
Abstract
BACKGROUND Psychometrically sound and time-efficient scales that measure depressive symptoms are essential for research and clinical practice. This study was aimed at exploring the psychometric properties of the Spanish version of the Clinically Useful Depression Outcome Scale (CUDOS) in a clinical sample. METHOD Participants were 162 patients (72% women) with a mood disorder (86% diagnosed as major depressive disorder). Depressive symptoms were assessed by means of the CUDOS, the Beck Depression Inventory (BDI), and two interviewer-rated instruments: the 17-item Hamilton Depression Rating Scale (HDRS17) and the Clinical Global Impression-Severity (CGI-S) scale. Dimensionality, internal consistency, test-retest reliability, construct validity, criterion validity, and responsiveness to change of the CUDOS were explored. RESULTS The CUDOS exhibited a one-factor structure which accounted for 55.7% of the variance, and excellent results for internal consistency (Cronbach's alpha=0.93), for test-retest reliability (intraclass correlation coefficient=0.84) and for convergent validity [HDRS17 (r=0.77), CGI-S (r=0.73) and BDI (r=0.89)]. The ability of the CUDOS to identify patients in remission was high (area under ROC curve=0.96). Its responsiveness to change was also highly satisfactory: patients with greater clinical improvement showed a greater decrease in CUDOS scores (p<0.001). LIMITATIONS Diagnoses, even though made by expert clinicians, were established as part of routine clinical practice. Generalizability of the findings beyond the study sample is unknown. CONCLUSIONS The findings suggest that the Spanish version of the CUDOS is valuable as a brief and psychometrically sound self-report instrument to assess depressive symptoms in research and in clinical practice.
Collapse
Affiliation(s)
- Joan Trujols
- Servei de Psiquiatria, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau), Barcelona, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain.
| | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Leventhal AM, Piper ME, Japuntich SJ, Baker TB, Cook JW. Anhedonia, depressed mood, and smoking cessation outcome. J Consult Clin Psychol 2013; 82:122-9. [PMID: 24219183 DOI: 10.1037/a0035046] [Citation(s) in RCA: 103] [Impact Index Per Article: 9.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
OBJECTIVE Although the relation between lifetime depression and smoking cessation outcome has been well studied, the proposition that different symptomatic expressions of depression exert disparate predictive effects on risk of smoking cessation failure has largely gone uninvestigated. This study analyzed the individual contributions of depression's 2 hallmark affective symptoms, anhedonia (i.e., diminished interest in normally enjoyable activities) and depressed mood (i.e., elevated sadness), to the prediction of smoking cessation outcome. METHOD Participants were adult daily smokers (N = 1,469; mean age = 45 years, 58% female, 84% White) enrolled in a smoking cessation treatment study. Lifetime history of anhedonia and depressed mood were classified via structured interview prior to quit day. Seven-day point prevalence smoking abstinence was assessed at 8 weeks and 6 months postquit. RESULTS When examined separately, both lifetime anhedonia, OR (95% CI) = 1.42 (1.16, 1.73), p = .004, and depressed mood, OR (95% CI) = 1.35 (1.11, 1.63), p = .002, predicted increased odds of relapse. These relations remained after adjusting for covariates, including lifetime depressive disorder, which did not predict outcome. After controlling for the covariation between lifetime anhedonia and depressed mood, anhedonia predicted cessation outcome, OR (95% CI) = 1.31 (1.05, 1.62), p = .02, while depressed mood did not (p = .19). Symptom duration (>2 weeks), treatment, and substance use disorder did not modify relations of lifetime anhedonia and depressed mood with cessation outcome. CONCLUSIONS Results suggest that (1) symptoms of affective disturbance capture depression-relevant risk of cessation failure, which is not adequately demarcated by the lifetime depressive disorder diagnosis, and (2) anhedonia is a more sensitive index of this affective disturbance than depressed mood per se. Clinical attention to anhedonia may facilitate smoking cessation.
Collapse
Affiliation(s)
- Adam M Leventhal
- Department of Preventive Medicine, University of Southern California Keck School of Medicine
| | - Megan E Piper
- Center for Tobacco Research and Intervention, Department of Medicine, University of Wisconsin School of Medicine and Public Health
| | | | - Timothy B Baker
- Center for Tobacco Research and Intervention, Department of Medicine, University of Wisconsin School of Medicine and Public Health
| | - Jessica W Cook
- Center for Tobacco Research and Intervention, Department of Medicine, University of Wisconsin School of Medicine and Public Health
| |
Collapse
|
11
|
Weight change and appetite disturbance as symptoms of adolescent depression: toward an integrative biopsychosocial model. Clin Psychol Rev 2009; 29:260-73. [PMID: 19250729 DOI: 10.1016/j.cpr.2009.01.007] [Citation(s) in RCA: 46] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2008] [Revised: 01/22/2009] [Accepted: 01/29/2009] [Indexed: 11/22/2022]
Abstract
The Diagnostic and Statistical Manual of Mental Disorders [American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.] lists weight change and appetite disturbance as a single compound symptom of depression at all ages. Nonetheless, assessment of these symptoms is complicated during adolescence by normative increases in body weight and appetitive drive as well as heightened rates of body dissatisfaction, dieting, and eating disorders. This review outlines biological and psychological mechanisms that may change the relation of weight change and appetite disturbance to depression during adolescence. We propose a developmental model of the relation of these symptoms to the disorder and use the model as a framework to summarize findings, limitations, and future directions of research. Although the literature suggests that weight change and appetite disturbance are related to adolescent depression, preliminary evidence suggests that interpretation of weight and appetite symptoms may depend on developmental level.
Collapse
|
12
|
Leventhal AM, Pettit JW, Lewinsohn PM. Characterizing major depression phenotypes by presence and type of psychomotor disturbance in adolescents and young adults. Depress Anxiety 2008; 25:575-92. [PMID: 17385727 DOI: 10.1002/da.20328] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Major depressive disorder (MDD) is phenomenologically heterogeneous, which has prompted investigation of intermediate MDD phenotypes based on specific key symptoms. Presence and type of psychomotor disturbance may be an important psychopathologic feature that differentiates clinically distinct forms of juvenile MDD. This study examined the phenotypic status of three putative MDD phenotypes in a community sample of 941 youths: (1) agitated depression (MDD with psychomotor agitation), (2) retarded depression (MDD with psychomotor retardation), and (3) agitated-retarded depression (MDD with psychomotor agitation and retardation within an episode). Hasler et al.'s [2004: Neuropsychopharmacology 29:1765-1781] criteria of specificity (degree of association with relevant symptoms and conditions related to the disease of interest versus other psychiatric conditions), stability (degree of stability over time), and heritability (degree of familial aggregation with relevant conditions) were used to evaluate the phenotypic significance of these subtypes. Results were suggestive that agitated depression was a relatively specific phenotypic syndrome characterized by irritability, arousal, physical complaints, and vulnerability to anxiety disorders and alcohol dependence; low stability across depressive episodes; and low heritability. Agitated-retarded depression was relatively specific and characterized by increased severity, recurrence, vegetative symptoms, suicidal ideation, social impairment, endogeneity, and vulnerability to anxiety disorders and bulimia; low stability across episodes; and modest heritability. Although retarded depression was associated with some specific distinguishing characteristics, most associations were explained by the increased severity of this phenotype. Retarded depression evidenced little stability or heritability. These findings offer partial support of the phenotypic status of agitated and agitated-retarded depression in youths.
Collapse
Affiliation(s)
- Adam M Leventhal
- Department of Psychiatry and Human Behavior, Brown Medical School, Providence, Rhode Island 02912, USA.
| | | | | |
Collapse
|
13
|
Leventhal AM, Witt CF, Zimmerman M. Associations between depression subtypes and substance use disorders. Psychiatry Res 2008; 161:43-50. [PMID: 18789540 PMCID: PMC2650805 DOI: 10.1016/j.psychres.2007.10.014] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/15/2007] [Revised: 07/06/2007] [Accepted: 10/24/2007] [Indexed: 11/26/2022]
Abstract
Evaluating whether certain subtypes of Major Depressive Disorder (MDD) are more strongly associated with Substance Use Disorders (SUDs) may help clarify reasons for MDD-SUD relations. Therefore, this study compared DSM-IV-defined non-atypical/non-melancholic depression (undifferentiated depression; n=365), atypical depression (n=117), melancholic depression (n=245), and atypical-melancholic depression (n=68) in the prevalence of current SUDs, while controlling for relevant demographic and clinical variables. Psychiatric outpatients with a current diagnosis of unipolar MDD were assessed using the Structured Clinical Interview for DSM-IV, supplemented by questions from the Schedule for Affective Disorders and Schizophrenia. Results showed that compared with patients with undifferentiated depression, melancholic patients had higher rates of current nicotine dependence (34% vs. 26%) and drug abuse/dependence (8% vs. 3%), Ps<0.05. These differences were explained by the association between specific melancholic features (marked psychomotor agitation and weight loss/decreased appetite) and nicotine and drug use disorders. Atypical depression, atypical-melancholic depression, and other subtype symptoms were not significantly associated with any SUDs. Although this study is limited by low prevalence of alcohol and drug use disorders, the present findings suggest that different symptomatic expressions of MDD differentially associate with some SUDs.
Collapse
Affiliation(s)
- Adam M. Leventhal
- Center for Alcohol and Addiction Studies, Brown University, Providence, RI, United States,Corresponding author. Center for Alcohol and Addiction Studies, Brown University, Box G-S121-4, Providence, RI, 02912, United States. Tel.: +1 713 305 4280; fax: +1 832 553 7714. E-mail address: (A.M. Leventhal)
| | - Caren Francione Witt
- Department of Psychiatry and Human Behavior, Brown Medical School, Providence, RI, United States
| | - Mark Zimmerman
- Department of Psychiatry and Human Behavior, Brown Medical School, Providence, RI, United States
| |
Collapse
|
14
|
Zimmerman M, McGlinchey JB, Young D, Chelminski I. Diagnosing major depressive disorder XII: can a self-report depression questionnaire be used to examine questions about the DSM-IV diagnostic criteria? J Nerv Ment Dis 2007; 195:158-64. [PMID: 17299304 DOI: 10.1097/01.nmd.0000254675.52952.e5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
This paper is the final one in our series examining the DSM-IV diagnostic criteria for major depressive disorder. The data collected were part of the Rhode Island Methods to Improve Diagnostic Assessment and Services project, a unique integration of a research assessment protocol into a community-based clinical practice. We were able to examine a number of psychometric and conceptual issues in the diagnosis of depression because we modified the diagnostic interview to inquire about all diagnostic criteria, as well as additional associated features, of all patients. The results reported in the papers published earlier in the series suggested that some changes in the diagnostic criteria might be warranted. However, before changes are made to the diagnostic nomenclature, the results of any single study should be replicated. The cost of conducting this type of research is high, thereby reducing the likelihood of replication. As part of the Methods to Improve Diagnostic Assessment and Services project, we developed the Diagnostic Inventory for Depression (DID), a self-report scale that was specifically designed to assess the DSM-IV diagnostic criteria for major depressive disorder; thus, this scale could potentially be used to study many of the same questions examined in the present series, though at a fraction of the cost. In the present report, we used the DID to examine questions that were addressed in three of the prior reports in this series. The results of the present analysis based on the DID replicated the previously reported findings based on the SCID. This suggests that a self-report measure such as the DID could be used in other settings to examine the issues studied in the present series of papers, thereby facilitating the compilation of a more substantial literature upon which decisions regarding criteria modification could be based.
Collapse
Affiliation(s)
- Mark Zimmerman
- Department of Psychiatry and Human Behavior, Brown University School of Medicine, Rhode Island Hospital, Providence, Rhode Island, USA
| | | | | | | |
Collapse
|
15
|
Zimmerman M, McGlinchey JB, Young D, Chelminski I. Diagnosing major depressive disorder IV: relationship between number of symptoms and the diagnosis of disorder. J Nerv Ment Dis 2006; 194:450-3. [PMID: 16772864 DOI: 10.1097/01.nmd.0000221425.04436.46] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
The symptom inclusion criteria for DSM-IV major depressive disorder (MDD) consist of a list of nine characteristic features of depression, at least five of which must be present. Two of the criteria for MDD, low mood and loss of interest or pleasure, are accorded greater importance than the remaining seven criteria in that one of these two features is required for the diagnosis. The implicit assumption underlying this organization of the criteria is that some individuals might meet five of the nine criteria without experiencing low mood or loss of interest or pleasure and thus be inappropriately diagnosed with major depression. We are not aware of any studies that have examined this assumption. In the present report from the Rhode Island Methods to Improve Diagnostic Assessment and Services project, we examined how many psychiatric outpatients meet five of the nine DSM-IV criteria for MDD without simultaneously experiencing either low mood or loss of interest or pleasure. If this pattern is rare or does not exist, then the method of counting criteria to diagnose major depression could be simplified to a straightforward five out of nine. Twenty-seven (1.5%) patients reported five or more criteria in the absence of low mood or loss of interest or pleasure. More than half (N = 16) of these 27 patients were diagnosed with MDD or bipolar disorder, depressed type, in partial remission (N = 14), bipolar disorder mixed type (N = 1), or bipolar disorder not otherwise specified (N = 1). Six of the remaining 11 patients were diagnosed with depressive disorder not otherwise specified. Thus, few patients who met five or more of the MDD criteria were not diagnosed with a depressive disorder. This suggests that the diagnostic criteria for MDD can be simplified to a straightforward symptom count without reference to the necessity of low mood or loss of interest or pleasure.
Collapse
Affiliation(s)
- Mark Zimmerman
- Department of Psychiatry and Human Behavior, Brown University School of Medicine, Rhode Island Hospital, Providence, Rhode Island, USA.
| | | | | | | |
Collapse
|